Barclays’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.3M | Sell |
|
|||||
|
2025
Q2 | $10.9M | Buy |
|
|||||
|
2025
Q1 | $1.66M | Sell |
|
|||||
|
2024
Q4 | $1.67M | Buy |
|
|||||
|
2024
Q3 | $1.62M | Buy |
|
|||||
|
2024
Q2 | $328K | Buy |
|
|||||
|
2024
Q1 | $306K | Sell |
|
|||||
|
2023
Q4 | $222K | Buy |
|
|||||
|
2023
Q3 | $66K | Sell |
|
|||||
|
2023
Q2 | $138K | Sell |
|
|||||
|
2023
Q1 | $232K | Buy |
|
|||||
|
2022
Q4 | $177K | Buy |
|
|||||
|
2022
Q3 | $106K | Sell |
|
|||||
|
2022
Q2 | $89K | Buy |
|
|||||
|
2022
Q1 | $60K | Buy |
|